A ganglion impar block (also known as a ganglion of Walther block) is a specialized interventional procedure targeting the solitary terminal ganglion of the sympathetic chain, located at the level of the sacrococcygeal junction. Unlike the paired, segmentally organized sympathetic ganglia of the thoracolumbar chain, the ganglion impar is a single, unpaired midline structure situated on the anterior surface of the coccyx, at the union of the sacrum and the first coccygeal segment. This ganglion provides sympathetic efferent innervation to the perineum, distal rectum, anus, distal urethra, vulva, scrotum, and coccyx — structures whose visceral pain signals are transmitted through the pelvic sympathetic chain and synapse at the ganglion impar before ascending to the superior hypogastric plexus and the spinal cord.
The primary indication for ganglion impar block is coccydynia, a painful and often debilitating condition characterized by focal pain and tenderness at the coccyx (tailbone) that is typically aggravated by prolonged sitting, rising from a seated position, and defecation. Coccydynia can result from a variety of causes, including acute or recurrent trauma (falling onto the buttocks, childbirth), postural and ergonomic factors (prolonged sitting on hard surfaces), hypermobility or subluxation of the coccyx, degenerative changes of the sacrococcygeal joint, and idiopathic causes. Beyond coccydynia, ganglion impar block is effective for chronic perineal pain, vulvodynia (vulvar pain syndrome with a suspected sympathetically maintained component), proctalgia (chronic anorectal pain), and pain from malignancies involving the distal rectum, anus, or pelvic floor.
The ganglion impar block is a technically demanding procedure that requires precise anatomic targeting and meticulous attention to sterile technique, given the proximity of the needle trajectory to the rectum, the sacrococcygeal ligaments, and the dural sac. At Interventional Pain Consultants, this procedure is performed by board-certified, fellowship-trained interventional pain specialists using multiplanar fluoroscopic guidance to ensure that the injectate is delivered precisely to the retrococcygeal space where the ganglion impar is located, maximizing therapeutic efficacy and minimizing the risk of complications.
The patient is positioned prone on the fluoroscopy table with a pillow under the lower abdomen to tilt the pelvis slightly and facilitate access to the sacrococcygeal region. After sterile preparation and draping from the lower lumbar region to the proximal thighs, the sacrococcygeal junction is identified under anteroposterior fluoroscopy. The most common and safest approach is the transsacrococcygeal (through the sacrococcygeal disc) or the transcoccygeal approach. In the transsacrococcygeal approach, a 22- or 25-gauge, 1.5- to 2.5-inch needle is advanced from a midline entry point at the level of the sacrococcygeal joint, directed through the sacrococcygeal ligament and the fibrocartilaginous disc connecting the sacrum and coccyx.
The needle is advanced under continuous fluoroscopic guidance using a lateral view to confirm the trajectory. The needle tip is positioned immediately anterior and inferior to the sacrococcygeal junction — the classic location of the ganglion impar, lying on the anterior surface of the coccyx. Correct positioning is confirmed by injecting 1-2 mL of non-ionic contrast medium: on the lateral fluoroscopic view, contrast is seen spreading in a linear, retrococcygeal pattern along the anterior surface of the coccyx. A lateral-only contrast pattern without ventral spread beyond the coccyx confirms that the injectate is confined to the target compartment. After negative aspiration, the therapeutic injectate is delivered — typically 3-6 mL of 0.25% bupivacaine combined with 40 mg of methylprednisolone acetate. For patients with cancer pain, neurolysis with 3-4 mL of 6-10% phenol or 50% ethanol may be employed.
The procedure is performed on an outpatient basis and requires approximately 15-20 minutes. The patient is positioned prone with a support pillow under the lower abdomen; this position is usually well-tolerated but may be uncomfortable for patients with significant coccydynia. Patients are awake throughout and may receive mild oral sedation if needed. The most uncomfortable portion of the procedure is typically the initial local anesthetic infiltration of the skin and the sensation of pressure as the needle traverses the sacrococcygeal ligament. The injection of the medication itself is typically painless.
Following the procedure, patients are monitored for 20-30 minutes. Immediate relief is common due to the local anesthetic component, and patients are often able to sit comfortably for the first time in weeks or months. Patients are given specific discharge instructions regarding activity restrictions, wound care, and the expected timeline of the corticosteroid response.
The local anesthetic effect provides immediate relief that lasts 4-8 hours. Patients are encouraged to test their ability to sit comfortably during this window but are cautioned to avoid prolonged sitting (more than 30-60 minutes at a time) and to use a cushion or coccygeal pillow (donut cushion) when seated. The corticosteroid begins to exert its anti-inflammatory effect within 2-7 days, with maximal benefit typically reached within 10-14 days.
Patients should avoid heavy lifting, prolonged sitting, sexual activity, and vigorous lower body exercise for 5-7 days following the procedure. The injection site in the sacrococcygeal region presents unique hygiene challenges; patients are instructed to gently cleanse the area with mild soap and water and to pat dry (rather than rub) for the first 48 hours. A series of 2-3 blocks spaced 4-6 weeks apart may be recommended for patients with chronic coccydynia. For patients who achieve excellent but temporary relief, pulsed radiofrequency ablation of the ganglion impar — a modification that delivers radiofrequency energy at sub-ablative temperatures — may provide longer-lasting benefit without the risks associated with chemical neurolysis.
Ganglion impar blocks are most effective in patients whose tailbone or perineal pain has a predominantly sympathetically maintained or visceral component. Patients with coccydynia who demonstrate focal tenderness at the coccyx on physical examination, pain reproduction with manipulation of the coccyx (on rectal examination or with passive coccygeal mobility testing), and pain that is reliably exacerbated by sitting and relieved by standing or leaning forward are generally considered optimal candidates. The presence of significant myofascial or musculoskeletal contributions to the pain — such as levator ani syndrome, piriformis syndrome, or gluteal trigger points — may require adjunctive treatments for optimal outcomes.
Contraindications include active infection in the sacrococcygeal region (including pilonidal sinus disease, presacral abscess, or sacral decubitus ulcers), coagulopathy or therapeutic anticoagulation that cannot be safely interrupted, known allergy to contrast media or injectate components, and anatomic abnormalities that preclude safe access to the ganglion impar (such as severe coccygeal fracture malunion, surgical absence of the coccyx, or extensive post-surgical or radiation-induced fibrosis). Pre-procedural imaging — particularly MRI of the sacrum and coccyx — is indicated for patients with atypical features, concern for infectious or neoplastic pathology, or a history of prior coccygeal surgery or trauma. At Interventional Pain Consultants, we are committed to a comprehensive, multidisciplinary approach to tailbone and pelvic pain management, integrating ganglion impar blocks with physical therapy (including pelvic floor rehabilitation and manual therapy), ergonomic optimization (cushion and workstation modification), medication management, and — when appropriate — surgical consultation for coccygectomy.
Reducing Pain. Improving Function. Enhancing Quality of Life.